Hyperthyroidism in the pregnant woman: Maternal and fetal aspects

Hyperthyroidism during pregnancy is uncommon. Nonetheless, prompt identification and adequate management of hyperthyroidism in a pregnant woman is essential, because uncontrolled thyrotoxicosis significantly increases the risk of maternal and fetal complications. Also, fetal prognosis may be affecte...

Full description

Bibliographic Details
Main Authors: Mariacarla Moleti, Maria Di Mauro, Giacomo Sturniolo, Marco Russo, Francesco Vermiglio
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Journal of Clinical & Translational Endocrinology
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623719300304
_version_ 1828766119616315392
author Mariacarla Moleti
Maria Di Mauro
Giacomo Sturniolo
Marco Russo
Francesco Vermiglio
author_facet Mariacarla Moleti
Maria Di Mauro
Giacomo Sturniolo
Marco Russo
Francesco Vermiglio
author_sort Mariacarla Moleti
collection DOAJ
description Hyperthyroidism during pregnancy is uncommon. Nonetheless, prompt identification and adequate management of hyperthyroidism in a pregnant woman is essential, because uncontrolled thyrotoxicosis significantly increases the risk of maternal and fetal complications. Also, fetal prognosis may be affected by the transplacental passage of maternal thyroid stimulating antibodies or thyrostatic agents, both of which may disrupt fetal thyroid function. Birth defects have been reported in association with the use of antithyroid drugs during early pregnancy. Although rarely, offspring of mothers with Graves’ disease may develop fetal/neonatal hyperthyroidism, the management of which requires a close collaboration between endocrinologists, obstetricians, and neonatologists.Because of the above considerations, the management of pregnant and lactating women with hyperthyroidism requires special care, bearing in mind that both maternal thyroid excess per se and related treatments may adversely affect the newborn’s health.In this review we discuss the diagnosis and management of hyperthyroidism in pregnancy, along with the impact of thyrotoxicosis and medications on fetal outcome. Keywords: Pregnancy, Hyperthyroidism, Thyrotoxicosis, Gestational transient thyrotoxicosis, Graves’ disease
first_indexed 2024-12-11T06:59:32Z
format Article
id doaj.art-e90bf6b29a2f4bf4ac2139c3d220a4d6
institution Directory Open Access Journal
issn 2214-6237
language English
last_indexed 2024-12-11T06:59:32Z
publishDate 2019-06-01
publisher Elsevier
record_format Article
series Journal of Clinical & Translational Endocrinology
spelling doaj.art-e90bf6b29a2f4bf4ac2139c3d220a4d62022-12-22T01:16:39ZengElsevierJournal of Clinical & Translational Endocrinology2214-62372019-06-0116Hyperthyroidism in the pregnant woman: Maternal and fetal aspectsMariacarla Moleti0Maria Di Mauro1Giacomo Sturniolo2Marco Russo3Francesco Vermiglio4Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 1, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 1, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 1, 98125 Messina, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 1, 98125 Messina, ItalyCorresponding author at: Via Consolare Valeria, 1, 98125 Messina, Italy.; Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 1, 98125 Messina, ItalyHyperthyroidism during pregnancy is uncommon. Nonetheless, prompt identification and adequate management of hyperthyroidism in a pregnant woman is essential, because uncontrolled thyrotoxicosis significantly increases the risk of maternal and fetal complications. Also, fetal prognosis may be affected by the transplacental passage of maternal thyroid stimulating antibodies or thyrostatic agents, both of which may disrupt fetal thyroid function. Birth defects have been reported in association with the use of antithyroid drugs during early pregnancy. Although rarely, offspring of mothers with Graves’ disease may develop fetal/neonatal hyperthyroidism, the management of which requires a close collaboration between endocrinologists, obstetricians, and neonatologists.Because of the above considerations, the management of pregnant and lactating women with hyperthyroidism requires special care, bearing in mind that both maternal thyroid excess per se and related treatments may adversely affect the newborn’s health.In this review we discuss the diagnosis and management of hyperthyroidism in pregnancy, along with the impact of thyrotoxicosis and medications on fetal outcome. Keywords: Pregnancy, Hyperthyroidism, Thyrotoxicosis, Gestational transient thyrotoxicosis, Graves’ diseasehttp://www.sciencedirect.com/science/article/pii/S2214623719300304
spellingShingle Mariacarla Moleti
Maria Di Mauro
Giacomo Sturniolo
Marco Russo
Francesco Vermiglio
Hyperthyroidism in the pregnant woman: Maternal and fetal aspects
Journal of Clinical & Translational Endocrinology
title Hyperthyroidism in the pregnant woman: Maternal and fetal aspects
title_full Hyperthyroidism in the pregnant woman: Maternal and fetal aspects
title_fullStr Hyperthyroidism in the pregnant woman: Maternal and fetal aspects
title_full_unstemmed Hyperthyroidism in the pregnant woman: Maternal and fetal aspects
title_short Hyperthyroidism in the pregnant woman: Maternal and fetal aspects
title_sort hyperthyroidism in the pregnant woman maternal and fetal aspects
url http://www.sciencedirect.com/science/article/pii/S2214623719300304
work_keys_str_mv AT mariacarlamoleti hyperthyroidisminthepregnantwomanmaternalandfetalaspects
AT mariadimauro hyperthyroidisminthepregnantwomanmaternalandfetalaspects
AT giacomosturniolo hyperthyroidisminthepregnantwomanmaternalandfetalaspects
AT marcorusso hyperthyroidisminthepregnantwomanmaternalandfetalaspects
AT francescovermiglio hyperthyroidisminthepregnantwomanmaternalandfetalaspects